Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

An Investigational Immuno-therapy Study of Experimental Medication BMS-986179 Given Alone and in Combination With Nivolumab

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02754141
Recruitment Status : Active, not recruiting
First Posted : April 28, 2016
Last Update Posted : December 7, 2021
Information provided by (Responsible Party):
Bristol-Myers Squibb

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : February 20, 2023
Estimated Study Completion Date : February 21, 2023